BioSpace News Archive

Pharm Country

BMS Releases Positive Long-Term Data for RCC Patients Treated with Opdivo and Yervoy

Long-term data boosts the efficacy of Bristol-Myers Squibb’s checkpoint inhibitor, Opdivo, as a treatment for renal cell carcinoma.

February 17, 2020

·

3 min read

·

Alex Keown

Employer Resources

The Top 15 Culture-Focused Life Sciences Employers

The BioSpace Ideal Employer Report examined aspects regarding the importance of culture within life sciences organizations.

February 17, 2020

·

3 min read

·

Porschia Parker

Business

FDA to Study Instagram and Social Media Influencers

The U.S. Food and Drug Administration’s Office of Prescription Drug Promotion is interested in how social media affects the public’s perception of drugs.

February 17, 2020

·

5 min read

·

Mark Terry

Policy

PharmaMar and Jazz Eye Potential Approval of SCLC Drug Lurbinectedin

The U.S. Food and Drug Administration accepted the companies’ New Drug Application for lurbinectedin under Priority Review.

February 17, 2020

·

2 min read

·

Alex Keown

3 Tips for Handling a Co-Worker You Don’t Get Along With

Read on for tips on how to handle a difficult co-worker you just can’t get along with.

February 17, 2020

·

2 min read

·

Laura Brothers

Career Advice

When and How to Reach Out to Recruiters

When you’re ready for a new job, contacting employers is a no-brainer. But the same kind of clear-cut call to action doesn’t necessarily apply to contacting recruiters.

February 17, 2020

·

4 min read

·

Katharine Hansen, PhD

New Molecule Has the Potential of Stopping or Slowing Parkinson’s

Parkinson’s disease affects the brain’s nerve cells that produce dopamine. Researchers at the University of Helsinki have identified a molecule called BT13 that potentially can increase levels of dopamine.

February 17, 2020

·

2 min read

·

Mark Terry

Brain eating amoeba treatment can be possible with

Researchers Synthesize New Brain Eating Amoeba Treatment

Brain eating amoeba treatment is crucial in the current world as infections are rising. Moreover, it is very deadly, killing about 97% of infected patients.

February 17, 2020

·

3 min read

·

Mark Terry

Drug Development

Sensorion Receives Ethics Committee Approval to Include New Military Sites in SENS-401 Phase 2 study

New sites to recruit voluntary military personnel in ongoing Phase 2 study in Sudden Sensorineural Hearing Loss

February 17, 2020

·

4 min read

Deals

Orexo AB (publ.) has Resolved to Carry out Repurchases of own Shares

The board of Orexo AB has resolved, pursuant to the authorisation granted by the annual general meeting held on 11 April 2019, to initiate a repurchase program of ordinary shares.

February 17, 2020

·

3 min read